Search
Displaying results 1 to 166 of 166.
Clara Lanfermann
Lara Lütke
Celine Beyer
Kaarem Haal
Erich Freyer
Julia Alpers
Dr Christian Niehaus
Prof Dr Yang Li
Beate Junk
Prof Dr Cheng-Jian Xu
Liang Zhou
Nienke van Unen
Javier Fransisco Botey-Bataller
Ahmed Alaswad
Dr Xun Jiang
Dr Saumya Dileep Kumar
Malou-Sophie Dietrich
Paulina Schröter
Yin-Han Chou
Dr Sebastian Klein
Prof Dr Anke Kraft
Prof Dr Markus Cornberg
Carlos Oltmanns
Moana Witte
Severin Wulf
Prof Dr Markus Cornberg and Prof Dr Anke Kraft
Roni Souleiman
Hannes Kolde
Ayesha Lietzau
Alina Diecke
Privacy policy
Data protection Thank you for your interest in our website. The Helmholtz Centre for Infection Research (HZI) takes the protection of personal data very seriously. It is possible to use our website without providing any personal data. This privacy policy…
Centre for Individualised Infection Medicine
Centre for Individualised Infection Medicine The CiiM, based in Hannover, is a joint research institute of the Helmholtz Centre for Infection Research and the Hannover Medical School. More about the CiiM Symposium 2026 The 2nd International Conference on…
Material on CiiM
Material on CiiM How is hepatitis D diagnosed? What happens if HDV infection is not treated? How is hepatitis D treated? Prof. Dr. Yang Li as part of the Cluster of Excellence RESIST Prof. Dr. Markus Cornberg as part of the Cluster of Excellence RESIST CiiM…
Prof Dr Till Strowig
Prof Dr Alice McHardy
Prof Dr Dr Luka Cicin-Sain
Imprint
Imprint according to the following German regulations: § 6 TDG, § 10 MDStV Publisher Helmholtz-Zentrum für Infektionsforschung GmbH (Helmholtz Centre for Infection Research) Inhoffenstraße 7 38124 Braunschweig Telefon: 0531 6181-0 Telefax: 0531 6181-2655…
Jobs
Jobs © AdobeStock_294726409 Initiativbewerbungen Become part of the team We are always interested in receiving applications from motivated candidates. More Contact Dr Jennifer Debarry +49 511 532 7226 E-Mail Further information
Our program
Our program Realising innovation Infections and their sequelae continue to account for one in five deaths worldwide. In this context, emerging and recurrent pathogens, chronic infections, as well as increasing resistance to approved drugs, continue to pose…
Prof Dr Markus Cornberg
Prof Dr Markus Cornberg CiiM Director +49 511 532 6821 E-Mail Markus Cornberg is W3-Professor Infectious Diseases with a focus on Hepatology and Deputy Director of the Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology at…
Dr Jennifer Debarry
Dr Jennifer Debarry +49 511 532 7226 E-Mail Jennifer Debarry has served as Science Manager since 2008 and, since 2015, has led the joint activities of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH) in individualised…
Prof Dr Yang Li
Prof Dr Yang Li CiiM Director +49 511 532 7200 E-Mail Yang Li has headed the Department of Computational Biology for Individualised Medicine at the CiiM and the HZI since 2019 and was also appointed Director of the CiiM. The focus of her research is on…
Prof Dr Markus Cornberg
Prof Dr med. Michael Peter Manns Head of Department +49 511 532 6048 E-Mail Michael Manns holds a senior professorship of the State of Lower Saxony with a focus on “Infection and Autoimmunity” at Hannover Medical School. In addition to his position at CiiM,…
Karen Susan Blume
Events
Events Scientific 19 March 2026 10.00 am Symposium 2nd International Conference on Individualized Infection Medicine Show more events Show all events
Publications
New research findings from CiiM Below you will find publications involving CiiM (as of March 2020): 2020 Author count: 8 Kastenmuller W., Gasteiger G., Subramanian N., Sparwasser Tim*, Busch D.H., Belkaid Y., ... , Drexler I., Germain R.N. (2011) Regulatory…
What is Individualised Medicine?
What is Individualised Medicine? Topics What is Individualised Medicine? In medicine, the development and application of therapies with maximum efficacy and minimum side effects remains a fundamental challenge. In fact, approved therapies and medicines…
Herrenhausen Symposium
Event Archive Herrenhausen Symposium Individualised Infection Medicine: The Future is Now Infektionen sind nach wie vor eine der Haupttodesursachen weltweit. Individuell zugeschnittene Vorsorge und Therapien versprechen neue Heilungsmöglichkeiten. Wie aber…
CiiM Lecture Series
Event Archive CiiM Lecture Series Internationally renowned scientists from the field of Personalised Medicine are invited to the CiiM Lecture Series. It aims to bring together all scientists and doctors interested in personalised medicine from the various…
COVID-19 Patient Cohort
COVID-19 Patient Cohort Understanding individual risk and predictability of severe COVID-19 CiiM is involved in the establishment of a COVID-19 patient cohort. The project, led by Prof. Dr. Thomas Illig from the Hannover Unified Biobank (MHH), is funded by…
Media Centre
Media Centre Material on CiiM On the occasion of the Open Day at the MHH, we have compiled an insight into the research at CiiM and the construction progress of the future CiiM building. About the material Here you can download CiiM information material. We…
Event Archive
Event Archive CiiM Lecture Series Herrenhausen Symposium "Individualised Infection Medicine: The Future is Now" 25. Impfsymposium
Project D-Solve
D-SOLVE EU-Project Logo D-SOLVE The path to personalised hepatitis D treatment Hepatitis D is by far the most severe form of chronic viral hepatitis frequently leading to liver failure, hepatocellular carcinoma and death. However, there is very limited…
Location & Building
Location & Building A Designated Building for Individualized Infection Medicine The Location Hannover - Braunschweig is one of the most important German research regions in the field of infectiology. The close partnership between the HZI in Braunschweig and…
NUM
NUM Local Coordination Units (LCU) of the Network of University Medicine (NUM) Providing patients with optimal care, preventing infections and expanding healthcare is the mission statement of the Network of University Medicine (NUM), which was founded in…
Field of research
Field of research Individualized medicine Medicine has always strived to understand the specifics of each patient in order to provide the best possible individualized treatment. In this context, it has become increasingly clear in recent years that the…
Research Groups
The groups at CiiM Four research groups of the HZI and the MHH are currently directly assigned to CiiM and are housed in TWINCORE until the new building is commissioned. In addition, other professorships at MHH (some as joint appointments with HZI) are…
SARS-CoV-2 Research
SARS-CoV-2 Research Forschung SARS-CoV-2 Research The research groups at CiiM are collaborating to address various current issues in SARS-CoV-2 research. The very diverse clinical histories suggest that a mixture of epidemiological, genetic, and…
Ciim | Partner
Partner A strong network for the requirements of Individualized Infection Medicine The embedding of CiiM in the region's existing research network ensures access to patients, interdisciplinary expertise and state-of-the-art technology. Through the linkage,…
Team
Team Since its foundation in 2015, the CiiM has grown continuously and coordinative and administrative teams have been created alongside the research groups . Management Prof Dr Yang Li CiiM Director Computational Biology for Individualised Medicine +49 511…
Selected projects
Selected projects On the way to individualized infection medicine In various projects, the research groups of CiiM, but also groups of HZI, MHH and TWINCORE are dedicated to different questions in the field of infection medicine and lay important…
Topics
Topics What is Individualised Medicine? Facets and added value of Individualised Medicin Characteristics of Individualised Infection Medicine
Organisation
Organisation The Structure of the CiiM The CiiM is a joint scientific institution (§ 36 NHG) formed by the founding partners HZI and MHH and was established in 2015 with the signing of a Letter of Intent. The basic principles of the collaboration at CiiM…
Facets and added value of Individualised Medicine
Facets and added value of Individualised Medicine The page is under construction.
Melanie Rodenberg
Patrick Kaufhold
Dr Tetyana Yevsa
Dr Nasim Safaei
Cornelia Senske
Agata Anna Bielecka
Diego Enrique Ortiz Quiroga
Katrin Anja Winter
Dr Lisa Osbelt-Block
Dr Yvonne Neumann
Dr Youssef el Mouali Benomar
Dr Till Robin Lesker
Centre for Individualised Infection Medicine
The CiiM Centre for Individualised Infection Medicine The CiiM ( Centre for Individualised Infection Medicine ) is a joint initiative of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Hannover Medical School (MHH). The research…
Maeva Katzmarzyk
Karina Watzke
Ronja Friedhoff
Ayse Barut
Henrike Maaß
Tatjana Lüddecke
Dr Najat Bdeir
Dr Upasana Kulkarni
Dr Henning Jacobsen
Dr Natascha Gödecke
Claudia Munzel
Jobs at CiiM
Jobs at CiiM Applications Join the team CiiM is growing and the CiiM groups are always happy to receive applications from motivated and qualified candidates. Open job advertisements can be found on the group pages. In addition, speculative applications are…
Characteristics of Individualised Infection Medicine
Characteristics of Individualised Infection Medicine The page is under construction.
Liver transplantation: Pattern of chronic rejection decoded
Two types of rejection “Chronic and acute rejection differ in terms of cause, progression and treatment,” says first author Dr Bastian Engel, MHH-Clinical Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology (GHIE). “In chronic rejection,…
The CiiM mourns the loss of its founding director Prof. Michael Manns
"With Michael Manns, we have lost the initiator and architect of the CiiM. He pursued the vision of individualized infectious disease medicine with determination and created structures that form the basis of our work today. For me personally, he was a mentor, advisor,…
Comorbidities in HIV: Big data study reveals molecular links
“People with HIV often suffer from non-AIDS-related comorbidities such as cardiovascular disease, liver disease, or cancer. They are more prone to chronic inflammation in the body, which causes them to age faster and have a lower life expectancy than other people,” says…
Groundbreaking for the Centre for Individualised Infection Medicine (CiiM)
"The COVID-19 pandemic has just shown us how important infection research and personalised medicine are - and that research findings need to to be transferred more quickly from bench to bedside," said Lower Saxony's Science Minister Falko Mohrs. “The life sciences are…
CiiM Founders' Award given to Michael Manns
Prof. Dr. Michael Manns took on the role of founding director in 2015, thereby formally launching CiiM. Under his leadership and in close cooperation with the then managing director of the Helmholtz Centre for Infection Research, Prof. Dr. Dirk Heinz, crucial funding…
BCG Vaccine ‘Trains’ Immunity Through Lasting Epigenetic Rewiring
The Bacillus Calmette‑Guérin (BCG) vaccine, in use for nearly a century to protect against tuberculosis, has long intrigued scientists for its ability to confer non‑specific protection against other infections. A new study led by the Centre for Individualised Infection…
Lower Saxony honors the life's work of Professor Michael Manns
‘It is a particular pleasure for me to honour Professor Michael Manns with the Grand Cross of the Order of Merit of Lower Saxony. This is in recognition of an impressive life's work and a sign of our appreciation for an outstanding and highly renowned scientist in our…
Why the flu vaccine is less effective in older people
Every year at the beginning of October, the flu epidemic rolls around. “Because older people in particular have an increased risk of a severe course of the disease, effective vaccines are especially important for them,” says Prof. Yang Li, Scientific Director of the…
Lyme disease: Probability of developing the disease is genetically predisposed
If a tick is infected with the pathogen Borrelia burgdorferi s. l. (sensu lato = in the broader sense), these bacteria can be transmitted to humans through a tick bite and cause illness. Various organ systems can be affected: the skin, the nervous system or the joints.…
‘The star is the team!’
Full support from the state of Lower Saxony After the welcoming remarks by Dean of Research Professor Frank Bengel, Professor Hilfiker-Kleiner and Professor Manns were greeted with thunderous applause. Lower Saxony's Minister of Science Falko Mohrs emphasised that it…
New Research Center for Artificial Intelligence and causal methods in Medicine
The digitalization of the life sciences opens up completely new potential for tackling common diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases such as Alzheimer's. The Center therefore focuses on linking research data, clinical…
MHH Professor Tobias Welte passed away
Welte was a highly valued partner and colleague to many researchers at the HZI. Particularly close collaborations with Tobias Welte existed, for example, with the HZI "Epidemiology" department under the direction of Prof. Gérard Krause (now WHO) and currently Dr. Berit…
“Aging Clock” reveals aging processes in immune cells
As we age, our immune system also ages. We become more susceptible to infections, vaccinations work less well and the risk of developing immune-related disorders such as autoimmune diseases increases. “In order to better understand how and where exactly the immune…
ERC Proof of Concept Grant for Yang Li
“Prof. Dr. Yang Li impressively combines insights from the life sciences and data science in her research. In doing so, she is laying the foundation for new possibilities for individually adapted diagnoses and therapies in medicine. As head of the Centre for…
What leads to severe COVID-19?
The team was able to identify underlying regulators of the malfunction of the innate immune system in COVID-19 patients and confirm that certain already known genetic risk loci play a role in the development of COVID-19. The results have been published in the journal…
A virus lurking in the connective tissue
As part of the new study, Dr Katarzyna Sitnik, then working in the “Viral Immunology” department at the HZI, headed by Prof Luka Cicin-Sain, and her colleagues naturally infected mice with murine CMV (mCMV). This variant of the virus is used because human CMV (HCMV) is…
Five HZI scientists are “Highly-cited Researchers”
Bioinformatician Prof Alice McHardy uses computational techniques to research the human microbiome as well as viral and bacterial pathogens. She heads the department “Computational Biology for Infection Research” at BRICS (Braunschweig Integrated Center of Systems…
Hijacking in the immune system
Up to 90% of the world's population carries HCMV. In people with a normal immune system, the infection is usually subclinical, i.e. it does not cause any pronounced symptoms. However, in immunocompromised patients, such as organ transplant recipients, the infection can…
COVID-19 Patientenkohorte hilft bei Aufklärung des Patientenrisikos
Aus der MHH stammen Bioproben und Daten der „ COVID-19-Kohorte “, die seit März 2020 von unterschiedlich stark am Coronavirus SARS-CoV-2 erkrankten Patientinnen und Patienten sowie Kontrollproben von Menschen mit anderen Atemwegserkrankungen aus verschiedenen…
Joint symposium of HZI and McGill University on personalised infection medicine
Personalised infection medicine aims to take into account individual differences in the diagnosis and therapy of infectious diseases. The HZI and McGill University have been building a strategic cooperation on this topic for several years. Clinicians and scientists from…
Who benefits from immunotherapy against hepatitis B?
It is estimated that more than 250 million people worldwide are chronically infected with the hepatitis B virus. Cytotoxic T cells and T helper cells play an important role in fighting viral infections. The constant activation of these immune cells in chronically…
The path to personalised hepatitis D treatment
Hepatitis D is caused by coinfection of hepatitis B patients with the hepatitis D virus (HDV). Up to 20 Million individuals are infected with HDV worldwide including about 250.000 patients in the European Union. There is very limited knowledge on disease pathophysiology…
When the skin aches
It was already known that in both psoriasis and neurodermatitis, T-cells of the immune system migrate from the blood into the skin and drive the inflammation there. Detailed examination of T-cells in blood and skin now led to evidence that in atopic dermatitis they…
How does Long COVID develop? New piece of the puzzle found
After infection with the SARS-CoV-2 virus, up to ten percent of those affected in Germany develop Long COVID. The symptoms associated with it, such as fatigue, concentration problems, respiratory issues, or neurological problems, can last for months or years.…
